Home
Biocartis

Biocartis Market Share Analysis for August 2026

Biocartis aims to help improve patient access to molecular diagnostics tests that drive treatment decisions.

Health > Biotechnology and Pharmaceuticals

Domainbiocartis.com

Year Founded2007

Employees201 - 500

Annual Revenue$50M - $75M

Biocartis

Biocartis (including company regionals)

biocartis.com

See more website traffic and engagement information

Biocartis Revenue up to August 2026 is 50M - 75M

revenue generated by Biocartis top domains

Biocartis top domains revenue over 3 years

Revenue for Biocartis top domains

biocartis.com50M - 75M

See more with Sales Intelligence

Total visits to Biocartis's top domains

Understand Biocartis market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

biocartis.com9.5K

See more with Sales Intelligence

Avg. visit duration in Biocartis's top domains

Analyze Biocartis engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

biocartis.com00:04:45

See more with Sales Intelligence

Avg. pageviews on Biocartis's top domains

See how Biocartis keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

biocartis.com5.00

See more with Sales Intelligence

Biocartis top competitors by domain

Top similar sites in August 2026, ranked by their affinity

kariusdx.comCompany NameKariusEmployees51 - 200HQUnited States, California, Redwood CityAnnual revenue$15M - $25MTotal visits7.8KHealth > Biotechnology and Pharmaceuticals

Top technologies used by Biocartis

These are the website technologies, by industry, used by Biocartis top domains

Advertising (5)

Google Adsense

Social (4)

Facebook Connect

Content Management System (3)

Drupal

Email Services (3)

Microsoft Exchange Online

More Technologies

11

See all

News & Signals from Biocartis

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsBiocartis Group is developing precision oncology solutions on Jul 7th '26.Biocartis, Discovery Life Sciences collaborate to develop precision oncology solutions.

NewsBiocartis partnered with Discovery Life Sciences on Jul 7th '26.Itasca, IL, US and Huntsville, AL, US, 7 July 2026 - Today, Biocartis, an innovative molecular diagnostics company, and Discovery Life Sciences ("Discovery"), a global leader in biomarker specialty laboratory services and biospecimen solutions, are pleased to announce a strategic collaboration to deliver seamless, end-to-end precision oncology solutions to pharmaceutical and biotech customers worldwide.

NewsBiocartis Group is developing Rapid Gene Signature Test for Early Detection of Pancreatic Cancer on Jun 9th '26.Press release Biocartis NV: Biocartis Announces Agreement with City of Hope to Explore Development of Rapid Gene Signature Test for Early Detection of Pancreatic Cancer.